Bone Therapeutics SA BOTHE-BE:Euronext Brussels

*Data is delayed | EUR
Last | 10:27 AM CET
0.655quote price arrow down-0.019 (-2.82%)
Volume
2,528
52 week range
0.54 - 3.15
Loading...
  • Open0.674
  • Day High0.674
  • Day Low0.653
  • Prev Close0.674
  • 52 Week High3.15
  • 52 Week High Date02/15/21
  • 52 Week Low0.54
  • 52 Week Low Date12/20/21

Key Stats

  • Market Cap12.56M
  • Shares Out16.48M
  • 10 Day Average Volume97,166.73
  • Dividend-
  • Dividend Yield-
  • Beta0.15
  • YTD % Change-1.65

KEY STATS

  • Open0.674
  • Day High0.674
  • Day Low0.653
  • Prev Close0.674
  • 52 Week High3.15
  • 52 Week High Date02/15/21
  • 52 Week Low0.54
  • 52 Week Low Date12/20/21
  • Market Cap12.56M
  • Shares Out16.48M
  • 10 Day Average Volume97,166.73
  • Dividend-
  • Dividend Yield-
  • Beta0.15
  • YTD % Change-1.65

RATIOS/PROFITABILITY

  • EPS (TTM)-1.01
  • P/E (TTM)-0.65
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Bone Therapeutics SA

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Bone Therapeutics SA is a Belgium-based company developing cell therapy products. The Company develops cell therapy products for the treatment and regeneration of bone tissue and bone reconstruction applications, osteonecrosis, ununited fractures, and maxillo-facial reconstruction. It is engaged in research, enable adult stem cell isolation, expansion, and osteogenic differentiation.The Company’s therapeutic area focus is bone diseases, with extensions to joint, mainly...
Baron Stephenne
Chairman of the Board
Miguel Forte
Chief Executive Officer, Executive Director
Lieve Creten
Interim Chief Financial Officer
Benoit Moreaux
Chief Scientific and Technology Officer
Address
rue Auguste Piccard
37, Gosselies Belgique
Gosselies
6041
Belgium